Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Determination of stromal response to nab-paclitaxel plus gemcitabine in pancreatic cancer
2010-019075-30Phase 2Active
- Sponsor
- Fundación de Investigación HM Hospitales
- Start
- May 2010
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, single-arm trial of nab-paclitaxel in pancreatic cancer (PC), sponsored by Fundación de Investigación HM Hospitales. Started May 2010; status: active.
02
Drugs
nab-paclitaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2010-019075-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019075-30.